Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
Clinical trial NCT05660473 · RECRUITING
Trial details
- NCT number
- NCT05660473
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2027-12-15
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.